Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Mundipharma International
Mundipharma International
Activities:
Research & Development
X
LinkedIn
Trending Articles
Bevel edge or radius edge flat face tablets: Which is better for greater consumer acceptance?
Consumers and patients should perceive that their tablets are easy to swallow and devoid of any undesirable taste. Tablet manufacturers can influence acceptance of by producing...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Ingredients
Helsinn brings cancer pain management option to China
With the help of Mundipharma China Pharmaceutical, ALOXI IV will be used for the prevention of chemotherapy-induced nausea and vomiting (CINV) in China
Media
Grunenthal and Mundipharma enter commercial partnership in China
Grünenthal and Mundipharma announced they have entered into a License and Distribution Agreement
Media
Mundipharma and CellAct announce deal for development of smart chemo
CellAct has provided the Mundipharma network, of independent associated companies, the worldwide development, commercialisation and manufacturing rights to CAP7.1
Distribution
Mundipharma partners with Munir Sukhtian Group to strengthen its consumer healthcare business
Partnership to increases access to the HiGeen range of products for millions of people across the Middle East and Africa region
Research & Development
Mundipharma Laboratories and Purdue Pharma enter global partnership with Laboratorios Esteve
To drive innovation in pain management
Subscribe now